Ricerca Biosciences sells out to equity investment group

After conducting a thorough process to evaluate strategic acquisition offers for the company, the Ricerca Biosciences, board of directors awarded the purchase to Main Market Partners, a middle-market growth investment fund.

According to the company, the award was based on value, strategic commitment to the company's clients, employees, and external stakeholders, and an aggressive timetable for closing the transaction. Terms of the sale were not disclosed.

Clifford Croley of Main Market Partners and the new chief executive of Ricerca stated: "We are greatly impressed with Ricerca's excellent scientific track record. This acquisition represents our strong commitment to continue Ricerca's solid scientific project research in the drug safety, chemical development, and agrochemical market segments. We intend on introducing an aggressive growth strategy for the Ricerca business while at the same time enhancing the technical service offering of the company."